Alpine Immune Sciences to Present Data from RUBY-1, a Phase 1 Study of Povetacicept, at Upcoming Scientific Congresses

Alpine Immune Sciences, Inc. , a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, announced the Company will present... | May 19, 2023

Related Keywords

Seoul ,Soult Ukpyolsi ,South Korea ,Frankfurt ,Brandenburg ,Germany ,Italy ,Milan ,Lombardia , ,Nasdaq ,International Congress On Systemic Lupus Erythematosus ,European Congress ,Alpine Immune Sciences Inc ,Congress Centre ,Convention Center ,European Renal Association ,European Hematology Association ,Mico Convention Center ,Alpine Immune Sciences ,Linkedin ,Milan Convention Centre ,International Congress ,Systemic Lupus ,Scientific Meeting ,Placebo Controlled Phase ,Healthy Adult Volunteers ,Potent Dual ,Systemic Lupus Erythematosus ,Short Oral Presentation Session ,Conference Room ,Poster Tour Auditorium ,Autoimmune Cytopenias ,Messe Frankfurt ,Renal Association ,Autoimmune Glomerulonephritides ,Variety Session ,Immune Sciences ,Nc Stock Exchange ,News ,Information ,Press Release ,Alpine ,Immune ,Reading ,Immunotherapy ,Company ,Ocused ,N ,Developing ,Nnovative ,Treatments ,Or ,Autoimmune ,End ,Inflammatory ,Nnounced ,The ,Ill Alpn Us02083g1004 ,